RecruitingNCT06524843
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma
Sponsor
Costantino Errani
Enrollment
250 participants
Start Date
Sep 23, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age ≥ 18 years
- Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
- Availability of imaging and clinical data
- Availability of at least one follow-up during the last 12 months form diagnosis
Exclusion Criteria1
- At least one inclusion creteria not met
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERAnalysis
Analysis and review of imaging and clinical data
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06524843
Related Trials
Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
NCT069188601 location
Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
NCT061890791 location
Registry for Bone Metastases
NCT073914107 locations
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
NCT038235341 location
Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort
NCT023564971 location